The Catch-22 of appraisals on the quality of observational studies
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
Conflict of interest: The division of Pharmacoepidemiology and Pharmacotherapy employing author R.H.H.G. has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private–public-funded Top Institute Pharma (www.tipharma.nl, includes cofunding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; STROBE, Strengthening the reporting of observational epidemiology; STARD, Standards for Reporting of Diagnostic Accuracy; PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.
PII: S0895-4356(10)00175-7
doi:10.1016/j.jclinepi.2010.04.013
© 2010 Elsevier Inc. All rights reserved.
